These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6118859)

  • 1. A double-blind controlled trial of the effect of sodium cromoglycate in preventing relapse in ulcerative colitis.
    Whorwell PJ; Whorwell GM; Bamforth J; Colin Jones D; Down P; Edwards A; Gent AE; Golding P; Gough KR; Hellier MD; Isaacson P; Loehry CA; Milton-Thompson GJ; Smith CL; Waldram RP; Wright R
    Postgrad Med J; 1981 Jul; 57(669):436-8. PubMed ID: 6118859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative trial of sulphasalazine and oral sodium cromoglycate in the maintenance of remission in ulcerative colitis.
    Dronfield MW; Langman MJ
    Gut; 1978 Dec; 19(12):1136-9. PubMed ID: 33875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of disodium cromoglycate and sulphasalazine as maintenance therapy for ulcerative colitis.
    Willoughby CP; Heyworth MF; Piris J; Truelove SC
    Lancet; 1979 Jan; 1(8108):119-22. PubMed ID: 84148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disodium cromoglycate in the treatment of ulcerative colitis and Crohn's disease.
    Binder V; Elsborg L; Greibe J; Hendriksen C; Høj L; Jensen KB; Kristensen E; Madsen JR; Marner B; Riis P; Willumsen L
    Gut; 1981 Jan; 22(1):55-60. PubMed ID: 6780414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled trial comparing olsalazine and sulphasalazine for maintenance treatment of ulcerative colitis.
    Jewell DP; Ireland A
    Scand J Gastroenterol Suppl; 1988; 148():45-7. PubMed ID: 2906477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled trial of disodium cromoglycate in chronic persistent ulcerative colitis.
    Buckell NA; Gould SR; Day DW; Lennard-Jones JE; Edwards AM
    Gut; 1978 Dec; 19(12):1140-3. PubMed ID: 105970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disodium cromoglycate maintenance treatment of ulcerative colitis.
    Langman MJ; Dronfield MW
    Acta Allergol; 1977; Suppl 13():76-81. PubMed ID: 24321
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulphasalazine retention enemas in ulcerative colitis: a double-blind trial.
    Palmer KR; Goepel JR; Holdsworth CD
    Br Med J (Clin Res Ed); 1981 May; 282(6276):1571-3. PubMed ID: 6113021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current status of drug therapy of chronic inflammatory intestinal diseases].
    Auer IO
    Z Gastroenterol; 1983 Jul; 21(7):299-317. PubMed ID: 6137117
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of ulcerative colitis with olsalazine and sulphasalazine: efficacy and side-effects.
    Ewe K; Eckardt V; Kanzler G
    Scand J Gastroenterol Suppl; 1988; 148():70-5. PubMed ID: 2906479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olsalazine in the treatment of ulcerative colitis among patients intolerant of sulphasalazine: a prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial.
    Meyers S; Sachar DB; Present DH; Janowitz HD
    Scand J Gastroenterol Suppl; 1988; 148():29-37. PubMed ID: 2906474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium cromoglycate in proctitis and ulcerative colitis.
    Allan RN
    Br Med J (Clin Res Ed); 1982 Jan; 284(6309):70-1. PubMed ID: 6119135
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Sodium Cromoglycate on Acetic Acid-induced Ulcerative Colitis in Mice.
    Ghafouri Z; Seyyedian S; Nikbakht J; Kouhsari E; Bayat S; Zargar H; Houshmand G
    Korean J Gastroenterol; 2020 Jan; 75(1):39-45. PubMed ID: 31986572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse.
    Riley SA; Mani V; Goodman MJ; Herd ME; Dutt S; Turnberg LA
    Gut; 1988 May; 29(5):669-74. PubMed ID: 2899536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of ulcerative colitis with oral disodium cromoglycate. A double-blind controlled trial.
    Mani V; Lloyd G; Green FH; Fox H; Turnberg LA
    Lancet; 1976 Feb; 1(7957):439-41. PubMed ID: 55715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: Treatment of ulcerative colitis with disodium cromoglycate: a long-term double-blind clinical trial.
    Mani V; Lloyd G; Green F; Fox H; Turnberg LA
    Gut; 1975 Oct; 16(10):832. PubMed ID: 812780
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis.
    Ireland A; Mason CH; Jewell DP
    Gut; 1988 Jun; 29(6):835-7. PubMed ID: 2898422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of colonic eicosanoid concentrations as predictors of relapse in ulcerative colitis: double blind placebo controlled study on sulphasalazine maintenance treatment.
    Lauritsen K; Laursen LS; Bukhave K; Rask-Madsen J
    Gut; 1988 Oct; 29(10):1316-21. PubMed ID: 2904392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind comparison of olsalazine and sulphasalazine in active ulcerative colitis.
    Willoughby CP; Cowan RE; Gould SR; Machell RJ; Stewart JB
    Scand J Gastroenterol Suppl; 1988; 148():40-4. PubMed ID: 2906476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of ulcerative colitis.
    Watkinson G
    Practitioner; 1976 Jun; 216(1296):642-8. PubMed ID: 7781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.